SCHEDULE 13G/A: Crestview Entities Disclose 13% Stake in Fidelis Insurance Holdings
Beneficial Ownership Report
Crestview, L.L.C. and its affiliated investment entities have filed an amended Schedule 13G, reporting a combined beneficial ownership of 13.0% of Fidelis Insurance Holdings Ltd.'s common shares as of December 31, 2024.
Summary
- Crestview, L.L.C. and its related entities collectively beneficially own 14,510,040 common shares of Fidelis Insurance Holdings Ltd.
- This aggregate ownership represents 13.0% of the Issuer's common shares outstanding.
- The percentage is based on 111,726,363 common shares outstanding as of September 30, 2024, as reported in Fidelis Insurance Holdings Ltd.'s Form 6-K filed on November 12, 2024.
- Crestview Partners III GP, L.P. beneficially owns 9,802,138 shares, representing 8.8% of the class.
- Crestview Partners IV GP, L.P. beneficially owns 4,707,902 shares, representing 4.2% of the class.
- Daniel Kilpatrick, a member of Fidelis Insurance Holdings Ltd.'s board of directors, is a partner of Crestview, L.L.C. and Crestview Advisors, L.L.C., which provides investment advisory services to the investment funds.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain forward-looking statements or performance metrics that would indicate a strong positive or negative sentiment. It is a routine regulatory filing.
Positives
- The disclosure of a significant stake by a prominent investment firm like Crestview may signal institutional confidence in Fidelis Insurance Holdings Ltd.
Future Outlook
NA
Management Comments
- Evelyn C. Pellicone, Chief Financial Officer of Crestview, L.L.C., signed the filing on behalf of all reporting persons, certifying the information is true, complete, and correct to her knowledge and belief.
Industry Context
This filing indicates continued institutional investor interest in the insurance and reinsurance sector, with a private equity firm like Crestview maintaining a significant stake in a publicly traded entity like Fidelis Insurance Holdings Ltd.
Related Party Transactions
- Daniel Kilpatrick, a partner of Crestview, L.L.C., is also a member of the Issuer's (Fidelis Insurance Holdings Ltd.) board of directors, indicating a direct link between the reporting entity and the Issuer's governance.
Stakeholder Impact
- Shareholders may view the continued significant ownership by a major investment firm like Crestview as a sign of stability and confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of common shares outstanding calculation (111,726,363 shares). |
| 11/12/2024 | Date of Issuer's Form 6-K filing reporting shares outstanding. |
| 12/31/2024 | Date of event which requires the filing of this statement. |
| 02/14/2025 | Filing date of the Schedule 13G Amendment No. 1. |
Keywords
Fidelis Insurance Holdings Ltd, Crestview, Schedule 13G, beneficial ownership, institutional investor, common shares, insurance, reinsurance, investment fund
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.